Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review
Epilepsy is one of the most common neurological diseases in children. There is an unmet need for new objective methods that would facilitate and accelerate the diagnostic process, thus improving the prognosis. In many studies, the participation of microRNA in epileptogenesis has been confirmed. Ther...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/1/26 |
id |
doaj-a9b889bd158340acabd11b520b10bb9c |
---|---|
record_format |
Article |
spelling |
doaj-a9b889bd158340acabd11b520b10bb9c2021-01-05T00:01:11ZengMDPI AGLife2075-17292021-01-0111262610.3390/life11010026Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic ReviewBeata Rzepka-Migut0Justyna Paprocka1Department of Pediatric Neurology and Pediatrics, St. Queen Jadwiga’s Regional Clinical Hospital No. 2, 35-301 Rzeszów, PolandDepartment of Pediatric Neurology, Faculty of Medical Science in Katowice, Medical University of Silesia, 40-752 Katowice, PolandEpilepsy is one of the most common neurological diseases in children. There is an unmet need for new objective methods that would facilitate and accelerate the diagnostic process, thus improving the prognosis. In many studies, the participation of microRNA in epileptogenesis has been confirmed. Therefore, it seems to be a promising candidate for this role. Scientists show the possibility of using microRNAs as diagnostic and predictive biomarkers as well as novel therapeutic targets. Children with epilepsy would benefit particularly from the use of this innovative method. However, the number of studies related to this age group is very limited. This review is based on 10 studies in children and summarizes the information collected from studies on animal models and the adult population. A total of 136 manuscripts were included in the analysis. The aim of the review was to facilitate the design of studies in children and to draw attention to the challenges and traps related to the analysis of the results. Our review suggests a high potential for the use of microRNAs and the need for further research.https://www.mdpi.com/2075-1729/11/1/26microRNAmiRNAepilepsychildrenbiomarkerprognosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Beata Rzepka-Migut Justyna Paprocka |
spellingShingle |
Beata Rzepka-Migut Justyna Paprocka Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review Life microRNA miRNA epilepsy children biomarker prognosis |
author_facet |
Beata Rzepka-Migut Justyna Paprocka |
author_sort |
Beata Rzepka-Migut |
title |
Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review |
title_short |
Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review |
title_full |
Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review |
title_fullStr |
Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review |
title_full_unstemmed |
Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review |
title_sort |
prospects and limitations related to the use of microrna as a biomarker of epilepsy in children: a systematic review |
publisher |
MDPI AG |
series |
Life |
issn |
2075-1729 |
publishDate |
2021-01-01 |
description |
Epilepsy is one of the most common neurological diseases in children. There is an unmet need for new objective methods that would facilitate and accelerate the diagnostic process, thus improving the prognosis. In many studies, the participation of microRNA in epileptogenesis has been confirmed. Therefore, it seems to be a promising candidate for this role. Scientists show the possibility of using microRNAs as diagnostic and predictive biomarkers as well as novel therapeutic targets. Children with epilepsy would benefit particularly from the use of this innovative method. However, the number of studies related to this age group is very limited. This review is based on 10 studies in children and summarizes the information collected from studies on animal models and the adult population. A total of 136 manuscripts were included in the analysis. The aim of the review was to facilitate the design of studies in children and to draw attention to the challenges and traps related to the analysis of the results. Our review suggests a high potential for the use of microRNAs and the need for further research. |
topic |
microRNA miRNA epilepsy children biomarker prognosis |
url |
https://www.mdpi.com/2075-1729/11/1/26 |
work_keys_str_mv |
AT beatarzepkamigut prospectsandlimitationsrelatedtotheuseofmicrornaasabiomarkerofepilepsyinchildrenasystematicreview AT justynapaprocka prospectsandlimitationsrelatedtotheuseofmicrornaasabiomarkerofepilepsyinchildrenasystematicreview |
_version_ |
1724348793211584512 |